BOOM

Trending Searches

    SUPPORT
    BOOM

    Trending News

      • Fact Check 
        • Fast Check
        • Politics
        • Business
        • Entertainment
        • Social
        • Sports
        • World
      • Law
      • Explainers
      • News 
        • All News
      • Decode 
        • Impact
        • Scamcheck
        • Life
        • Voices
      • Media Buddhi 
        • Digital Buddhi
        • Senior Citizens
        • Videos
      • Web Stories
      • BOOM Research
      • BOOM Labs
      • Deepfake Tracker
      • Videos 
        • Facts Neeti
      • Home-icon
        Home
      • About Us-icon
        About Us
      • Authors-icon
        Authors
      • Team-icon
        Team
      • Careers-icon
        Careers
      • Internship-icon
        Internship
      • Contact Us-icon
        Contact Us
      • Methodology-icon
        Methodology
      • Correction Policy-icon
        Correction Policy
      • Non-Partnership Policy-icon
        Non-Partnership Policy
      • Cookie Policy-icon
        Cookie Policy
      • Grievance Redressal-icon
        Grievance Redressal
      • Republishing Guidelines-icon
        Republishing Guidelines
      • Fact Check-icon
        Fact Check
        Fast Check
        Politics
        Business
        Entertainment
        Social
        Sports
        World
      • Law-icon
        Law
      • Explainers-icon
        Explainers
      • News-icon
        News
        All News
      • Decode-icon
        Decode
        Impact
        Scamcheck
        Life
        Voices
      • Media Buddhi-icon
        Media Buddhi
        Digital Buddhi
        Senior Citizens
        Videos
      • Web Stories-icon
        Web Stories
      • BOOM Research-icon
        BOOM Research
      • BOOM Labs-icon
        BOOM Labs
      • Deepfake Tracker-icon
        Deepfake Tracker
      • Videos-icon
        Videos
        Facts Neeti
      Trending Tags
      TRENDING
      • #Operation Sindoor
      • #Pahalgam Terror Attack
      • #Narendra Modi
      • #Rahul Gandhi
      • #Waqf Amendment Bill
      • #Arvind Kejriwal
      • #Deepfake
      • #Artificial Intelligence
      • Home
      • Coronavirus
      • US FDA Approves Emergency Use...
      Coronavirus

      US FDA Approves Emergency Use Authorization For Pfizer

      Pfizer vaccine becomes the first company to receive the COVID-19 approval

      By - Shachi Sutaria |
      Published -  12 Dec 2020 8:07 PM IST
    • Boomlive
      US FDA Approves Emergency Use Authorization For Pfizer

      The US Food and Drug Administration (FDA) has granted emergency use authorization to Pfizer-BioNTech's mRNA COVID-19 vaccine making it the first vaccine to receive approval in the country with the highest number of COVID-19 cases and deaths.

      After receiving authorization in the UK, the Pfizer vaccine will now be distributed in the US. Emergency use authorization is granted before a drug/vaccine has completed clinical trials due to the nature of medical emergency. In the pandemic, Pfizer's Phae 3 trials interim results have shown a 95% efficacy against SARS-CoV-2.

      "Today's action follows an open and transparent review process that included input from independent scientific and public health experts and a thorough evaluation by the agency's career scientists to ensure this vaccine met FDA's rigorous, scientific standards for safety, effectiveness, and manufacturing quality needed to support emergency use authorization," said FDA Commissioner Stephen Hahn in a statement. He even identified these efforts by all the vaccine manufacturers to produce a vaccine against a novel vaccine in short durations as a true testament to scientific innovation and public-private collaboration worldwide.

      The vaccine can be administered to people older than 16 years of age. The current data is insufficient to decide whether children can receive the vaccine, FDA officials stated.

      Pfizer- BioNTech have employed an mRNA which contains the spike protein from SARS-CoV-2 that will elicit an immune response in the people it has been administered too. Another American vaccine produced by Moderna seeking EUA from the FDA uses the same technology. Both the vaccines have shown over 90% efficacy against the virus.

      Requiring storage at -70ºC, the vaccine has to be given in two dosages three weeks apart. The vaccine manufacturers have provided data for 37,586 of the participants. While the FDA reported over four participants suffering from temporary facial paralysis (Bell's Palsy) after taking the vaccine, the FDA believes that the vaccine is still safe to be used. A link between the vaccine and these cases has so far not been established.

      With over 95% effectiveness assured by the FDA, the vaccine will begin distribution in the US soon. The company has also applied to the Indian drug regulator for disseminating its doses but is yet to present in front of the Subject Expert Committee.

      Also Read:No, This Is Not The Family Portrait Of COVID-19 Vaccine Developer


      Also Read:UK Approves Pfizer-BioNTech COVID-19 Vaccine; Roll Out From Next Week


      Tags

      pfizerCOVID-19CoronavirusFDAUS FDA
      Read Full Article
      Next Story
      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker. Please reload after ad blocker is disabled.
      X

      Subscribe to BOOM Newsletters

      👉 No spam, no paywall — but verified insights.

      Please enter a Email Address
      Subscribe for free!

      Stay Ahead of Misinformation!

      Please enter a Email Address
      Subscribe Now🛡️ 100% Privacy Protected | No Spam, Just Facts
      By subscribing, you agree with the Terms & conditions and Privacy Policy connected to the offer

      Thank you for subscribing!

      You’re now part of the BOOM community.

      Or, Subscribe to receive latest news via email
      Subscribed Successfully...
      Copy HTMLHTML is copied!
      There's no data to copy!